Warning: The NCBI web site requires JavaScript to function. more...
Drug procurement, the Global Fund and misguided competition policies.
Tren R, Hess K, Bate R.
Malar J. 2009 Dec 22;8:305.
Related citations
Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.
Smith N, Obala A, Simiyu C, Menya D, Khwa-Otsyula B, O'Meara WP.
Malar J. 2011 Oct 26;10:316.
Malaria drug shortages in Kenya: a major failure to provide access to effective treatment.
Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, Goodman CA, Zurovac D, Snow RW.
Am J Trop Med Hyg. 2009 May;80(5):737-8.
Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.
Njogu J, Akhwale W, Hamer DH, Zurovac D.
East Afr Med J. 2008 May;85(5):213-21.
Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.
Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H, Lengeler C.
Malar J. 2010 Jun 15;9:164.
SMS for Life: a pilot project to improve anti-malarial drug supply management in rural Tanzania using standard technology.
Barrington J, Wereko-Brobby O, Ward P, Mwafongo W, Kungulwe S.
Malar J. 2010 Oct 27;9:298.
Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania.
Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, Bishop D, Odhiambo M, Ward L, Goodman C.
PLoS One. 2009 Sep 2;4(9):e6857.
The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets.
Larson BA, Amin AA, Noor AM, Zurovac D, Snow RW.
BMC Public Health. 2006 Dec 29;6:314.
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW.
Malar J. 2007 May 29;6:72.
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
Zurovac D, Ndhlovu M, Sipilanyambe N, Chanda P, Hamer DH, Simon JL, Snow RW.
Malar J. 2007 Mar 16;6:31.
The ACTwatch project: methods to describe anti-malarial markets in seven countries.
Shewchuk T, O'Connell KA, Goodman C, Hanson K, Chapman S, Chavasse D.
Malar J. 2011 Oct 31;10:325.
The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.
Zurovac D, Larson BA, Akhwale W, Snow RW.
Trop Med Int Health. 2006 Aug;11(8):1185-94.
Cost-effectiveness study of three antimalarial drug combinations in Tanzania.
Wiseman V, Kim M, Mutabingwa TK, Whitty CJ.
PLoS Med. 2006 Oct;3(10):e373.
Physical and chemical stability of expired fixed dose combination artemether-lumefantrine in uncontrolled tropical conditions.
Bate R, Tren R, Hess K, Attaran A.
Malar J. 2009 Feb 25;8:33.
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
Wasunna B, Zurovac D, Goodman CA, Snow RW.
Malar J. 2008 Feb 5;7:29.
A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.
Ajayi IO, Falade CO, Olley BO, Yusuf B, Gbotosho S, Iyiola T, Olaniyan O, Happi C, Munguti K, Pagnoni F.
BMC Health Serv Res. 2008 Jun 1;8:119.
Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys.
Littrell M, Gatakaa H, Phok S, Allen H, Yeung S, Chuor CM, Dysoley L, Socheat D, Spiers A, White C, Shewchuk T, Chavasse D, O'Connell KA.
Malar J. 2011 Oct 31;10:328.
Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa.
Muheki C, McIntyre D, Barnes KI.
Trop Med Int Health. 2004 Sep;9(9):959-66.
Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
Zurovac D, Tibenderana JK, Nankabirwa J, Ssekitooleko J, Njogu JN, Rwakimari JB, Meek S, Talisuna A, Snow RW.
Malar J. 2008 Sep 19;7:181.
A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
Juma EA, Obonyo CO, Akhwale WS, Ogutu BR.
Malar J. 2008 Dec 22;7:262.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on